Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 09, 2024

SELL
$6.32 - $10.46 $442,918 - $733,057
-70,082 Reduced 56.77%
53,369 $405,000
Q1 2024

May 09, 2024

BUY
$4.51 - $8.92 $556,764 - $1.1 Million
123,451 New
123,451 $1.06 Million
Q2 2023

Aug 10, 2023

BUY
$5.0 - $6.31 $54,545 - $68,835
10,909 New
10,909 $55,000
Q3 2022

Nov 10, 2022

SELL
$10.02 - $26.15 $961 - $2,510
-96 Reduced 0.03%
288,883 $2.98 Million
Q2 2022

Aug 05, 2022

BUY
$6.5 - $13.68 $1.88 Million - $3.95 Million
288,979 New
288,979 $3.35 Million

Others Institutions Holding SIGA

About SIGA TECHNOLOGIES INC


  • Ticker SIGA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 73,024,096
  • Market Cap $432M
  • Description
  • SIGA Technologies, Inc., a commercial-stage pharmaceutical company, focuses on the health security and infectious disease markets in the United States. Its lead product is TPOXX, an oral formulation antiviral drug for the treatment of human smallpox disease caused by variola virus. SIGA Technologies, Inc. has a strategic partnership with Cipla T...
More about SIGA
Track This Portfolio

Track Connor, Clark & Lunn Investment Management Ltd. Portfolio

Follow Connor, Clark & Lunn Investment Management Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Connor, Clark & Lunn Investment Management Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Connor, Clark & Lunn Investment Management Ltd. with notifications on news.